Nirupama Ramadas; Erica Sparkenbaugh/LinkedIn
Nov 3, 2025, 04:56
Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
RPTH Journal shared on LinkedIn:
”Sickle cell disease (SCD) is more than a hemoglobinopathy, it’s a chronic thrombo-inflammatory disorder.
This review from Nirupama Ramadas and Erica Sparkenbaugh explores how hemolysis, endothelial activation, and cellular aggregates drive thrombosis, organ injury, and inflammation, and what that means for future therapies.
Read more.”
Read the full article in RPTH.
Article: Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis
Authors: Nirupama Ramadas, Erica Sparkenbaugh
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering